All treatments
Treatment
SCD-044 Tablets 0.3mg clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Plaque Psoriasis
This study is looking into a new tablet called SCD-044 for people aged 18 and over with moderate to severe plaque psoriasis. It wants to see if different doses of this tablet can improve skin more than a dummy pill (placebo) after 16 weeks, and if it's safe to use.
For: moderate to severe plaque psoriasisPoland · Estonia - Ongoing, recruitingTherapeutic exploratory (Phase II)
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF SCD-044 IN THE TREATMENT OF MODERATE TO SEVERE ATOPIC DERMATITIS
This study is testing a new medicine, SCD-044, for people with moderate to severe eczema (atopic dermatitis). Researchers want to see if different doses of this medicine are safe and help improve eczema symptoms by a lot.
For: atopic dermatitisPoland · Estonia